Trials / Unknown
UnknownNCT04221399
Type 2 Diabetes Patients With Renal Impairment
A Single- and Multiple-Dose Clinical Study to Evaluate Pharmacokinetics and Pharmacodynamics of DWP16001 Following Oral Dose in Type 2 Diabetes Patients With Renal Impairment
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the effect of kidney function on pharmacokinetics and pharmacodynamics of DWP16001 following single and multiple oral doses in type 2 diabetes patients with normal kidney function and renal impairment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP16001 | Tablets, Oral, Once daily, Single dose |
| DRUG | DWP16001 | Tablets, Oral, Once daily, Multiple dose |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-08-01
- Completion
- 2020-10-01
- First posted
- 2020-01-09
- Last updated
- 2020-01-09
Source: ClinicalTrials.gov record NCT04221399. Inclusion in this directory is not an endorsement.